Severe Fentanyl Withdrawal Associated With Medetomidine Adulteration: A Multicenter Study From Philadelphia, PA
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to wishlist failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Unfollow podcast failed
Severe Fentanyl Withdrawal Associated With Medetomidine Adulteration: A Multicenter Study From Philadelphia, PA
-
Narrated by:
-
By:
In this episode of Beyond The Abstract, Dr. Phil Durney and Dr. Kory London stop by the show to discuss their latest article featured in the current March/April issue of the Journal of Addiction Medicine titled Severe Fentanyl Withdrawal Associated With Medetomidine Adulteration: A Multicenter Study From Philadelphia, PA.
They discuss what medetomidine is, how it functions, and how its emergence in the fentanyl supply is impacting the opioid crisis in the US, as well as clinical management of medetomidine exposure and withdrawal in hospital and outpatient settings.
Article Link: Severe Fentanyl Withdrawal Associated With Medetomidine Adulteration: A Multicenter Study From Philadelphia, PA
adbl_web_anon_alc_button_suppression_t1
No reviews yet